pharmacie et médicaments – Sur les risques sanitaires et les pénuries liés au détournement de l'Ozempic

This written question addresses concerns about the diversion of Ozempic, a medication primarily for diabetes, for non-approved uses like weight loss. It highlights potential health risks and shortages arising from this misuse. The question seeks information on the government's awareness of these issues and the measures being considered to ensure patient access to essential medicines and mitigate health risks.